Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Aston Martin limits US exports in response to tariffs; Losses narrow

(Sharecast News) - Luxury carmaker Aston Martin is limiting exports to the US in response to President Donald Trump's tariffs and also managed to post narrower-than-expected first-quarter losses. Trump slapped a 25% levy on all auto and parts imports, although he pledged some relief on Tuesday amid fears his measure could hurt US factories.

"We are carefully monitoring the evolving U.S. tariff situation and are currently limiting imports to the US. while leveraging the stock held by our U.S. dealers. We remain vigilant in monitoring events and will respond to changes in the operating environment as they materialise, Aston Martin said on Wednesday.

The company reported an adjusted pre-tax loss of £79.8m for the three-months to March 31, compared with £110.5m a year ago, and consensus estimates of £89m.

"In the year ahead, we will complement the core portfolio through the delivery of further derivatives including the DBX S, which expands our SUV range and offers customers even more power, reduced weight and a more assertive design," said chief executive Adrian Hallmark.

"We are now in the final testing phase of the groundbreaking supercar, Valhalla, our first mid-engined Plug in Hybrid Electric Vehicle, with deliveries set to commence in H2."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.